Shanghai: Undelisted, Libang, Jinshan heavy varieties suspended procurement for 1 year

The notice shows that, in accordance with the provisions of the Notice on Further Strengthening the Administration of the Purchase and Use of Self-funded Medicines by The City's Medical Insurance Designated Medical Institutions (Shanghai People's Social Medical Association (2017) No. 263) and the Notice on Further Improving the Purchase of the City's Self-funded Drug Network (Shanghai Pharmaceuticals (2017) No. 29), the suspension of some of the drugs that do not comply with the relevant provisions of the self-funded drug registration network shall be suspended for one year from January 15, 2021.
involved in products mainly produced by Xi'an Libang Pharmaceutical Co., Ltd. for the forefront of the injection (1 ml:5ug, glass ampoules), undelievered biopharmaceutical Co., Ltd. production of injection mouse nerve growth factor (18 μg (≥900) 0A's/branch/bottle, Xilin bottle, 1/box), Malay acid cinnamon zitt injection (2 ml:80mg/branch, ampoule, 4 x/box) produced by Fujian Jinshan Biopharmaceutical Co., Ltd.